Geron Corp

General ticker "GERN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.6B

Geron Corp follows the US Stock Market performance with the rate: 48.4%.

Estimated limits based on current volatility of 3.6%: low 3.45$, high 3.70$

Factors to consider:

  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.67$, 3.37$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.61$, 3.29$]

Financial Metrics affecting the GERN estimates:

  • Negative: Non-GAAP EPS, $ of -0.33 <= 0.10
  • Negative: Operating profit margin, % of -99.88 <= 1.03
  • Negative: Operating cash flow per share per price, % of -12.41 <= 2.35
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Net income
  • Positive: -0.96 < Investing cash flow per share, $ of -0.32
  • Positive: Inventory ratio change, % of -84.06 <= -1.03

Similar symbols

Short-term GERN quotes

Long-term GERN plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $1.39MM $0.60MM $0.24MM
Operating Expenses $115.39MM $139.15MM $194.18MM
Operating Income $-114.00MM $-138.55MM $-193.94MM
Non-Operating Income $-3.21MM $-3.35MM $9.82MM
Interest Expense $3.74MM $6.88MM $8.31MM
R&D Expense $85.73MM $95.52MM $125.05MM
Income(Loss) $-117.21MM $-141.90MM $-184.13MM
Profit(Loss) $-117.21MM $-141.90MM $-184.13MM
Stockholders Equity $126.42MM $80.00MM $247.95MM
Inventory $1.40MM $3.14MM $0.00MM
Assets $226.03MM $190.57MM $394.08MM
Operating Cash Flow $-95.56MM $-127.38MM $-167.74MM
Capital expenditure $0.21MM $0.43MM $0.83MM
Investing Cash Flow $71.95MM $62.07MM $-180.32MM
Financing Cash Flow $48.56MM $87.26MM $362.02MM
Earnings Per Share* $-0.37 $-0.37 $-0.32

* EPS are Split Adjusted, recent splits may be reflected with a delay.